Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
Serre-Yu Wong, Rebekah E. Dixon, Vicky Martinez Pazos, Sacha Gnjatic, Jean‐Frédéric Colombel, Ken Cadwell, Stephanie Gold, Drew Helmus, Jessica A. Neil, Stela Sota, Kyung Ku Jang, Krystal L. Ching, Mericien Venzon, Xiaomin Yao, Lucie Bernard, Xin Chen, Reema Navalurkar, Michelle Mendiolaza, Pamela Reyes-Mercedes, Sara Núñez, Stephanie Stanley, Darwin Jimenez, Michael Tankelevich, Brianne Phillipe, Julio Ramos, Kevin Tuballes, Vanessa Barcessat, Natalia G. Herrera, Jack Satsangi, Kenji Watanabe, Séverine Vermeire, Flávio Steinwurz, Mark S. Silverberg, David T. Rubin, Giulia Roda, Walter Reinisch, Siew C. Ng, James O. Lindsay, Jonas Halfvarson, Matthieu Allez, Vineet Ahuja, María T. Abreu
Topics & Concepts
MedicineInflammatory bowel diseaseInfliximabUlcerative colitisDiseaseInternal medicineCoronavirusColitisImmunologySerologyGastroenterologyAntibodyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchInflammatory Bowel DiseaseCOVID-19 Clinical Research Studies